0001209191-21-007312.txt : 20210203
0001209191-21-007312.hdr.sgml : 20210203
20210203170027
ACCESSION NUMBER: 0001209191-21-007312
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210201
FILED AS OF DATE: 20210203
DATE AS OF CHANGE: 20210203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: THOMAS FRANK E
CENTRAL INDEX KEY: 0001242616
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38722
FILM NUMBER: 21586999
MAIL ADDRESS:
STREET 1: C/O ORCHARD THERAPEUTICS
STREET 2: 101 SEAPORT BOULEVARD, 7TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Orchard Therapeutics plc
CENTRAL INDEX KEY: 0001748907
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 108 CANNON STREET
CITY: LONDON
STATE: X0
ZIP: EC4N 6EU
BUSINESS PHONE: 011-44-0-203-3846700
MAIL ADDRESS:
STREET 1: 108 CANNON STREET
CITY: LONDON
STATE: X0
ZIP: EC4N 6EU
FORMER COMPANY:
FORMER CONFORMED NAME: Orchard Rx Ltd
DATE OF NAME CHANGE: 20180802
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-01
0
0001748907
Orchard Therapeutics plc
ORTX
0001242616
THOMAS FRANK E
C/O ORCHARD THERAPEUTICS PLC
108 CANNON STREET
LONDON
X0
EC4N 6EU
UNITED KINGDOM
0
1
0
0
See Remarks
Stock Option (Right to Buy)
5.98
2021-02-01
4
A
0
27731
0.00
A
2031-01-31
Ordinary Shares
27731
27731
D
Stock Option (Right to Buy)
5.98
2021-02-01
4
A
0
310000
0.00
A
2031-01-31
Ordinary Shares
310000
310000
D
The shares subject to this option vest in 12 equal monthly installments commencing on February 1, 2021.
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
The shares subject to this option vest in equal monthly installments over the four years after February 1, 2021.
Title: President & Chief Operating Officer
/s/ Frank E. Thomas
2021-02-03